77 results on '"Klenerman, P."'
Search Results
2. A pan-genotype HCV T cell vaccine, in a simian adenovirus vector, to target T cell epitopes conserved across multiple HCV genotypes
3. No change in hepatitis C virus-specific T cell functionality after successful DAA treatment in chronic hepatitis C patients
4. Characterisation of resistance associated substitutions in direct acting antivirals treatment naive patients with genotype 3 hepatitis C virus
5. Distinct immune and regulatory functions of IgG1+ and IgG4+ B cells in IgG4-related disease
6. Clinical and translational outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease receiving vedolizumab
7. Helicobacter Pylori as a Microbial Antigen in IGG4-Related Disease
8. Vaccine-Induced HCV-Specific CD8+ T Cell Response Restricted by the Protective HLA Allele B*27: Broad Cross-Recognition of Evolving Viral Variants
9. Genome-To-Genome Virus-Host Analysis Reveals HCV Genotype 3 Viral Polymorphisms Linked Viral Load and to Host HLA Class-I/II and IL28B Alleles
10. IGG4-Related Disease is Associatied with CD4+ T Cell Activation and Regulation
11. Sequencing Methods Developed for Hepatitis C Identifies a New Virus, Human Hepegivirus 1, in Patients with Advanced Cirrhosis
12. Characterisation of the Specificity, Functionality and Durability of Host T-Cell Responses against the Full HEV Genome
13. The Generation of an Immunogenic Second-Generation Conserved Segment HCV T Cell Vaccine to Target Multiple HCV Genotypes
14. Comparison of next Generation Sequencing Technologies for the Comprehensive Assessment of Full-Length Hepatitis C Viral Genomes
15. SAT-431 - A pan-genotype HCV T cell vaccine, in a simian adenovirus vector, to target T cell epitopes conserved across multiple HCV genotypes
16. SAT-409 - Highly immunogenic virally vectored T cell vaccine against HCV are able to induce specific CD4+ T cell helper responses
17. IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION
18. IL28B GENETIC STATUS IN ASSOCIATION WITH HCV SPECIFIC T-CELL IMMUNITY
19. PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
20. A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
21. MULTIPLE NOVEL PEPTIDE EPITOPES IN HCV GENOTYPE-3A IDENTIFIED USING TWO PARALLEL APPROACHES
22. P1173 : Mait cells are enriched in portal tracts and respond to biliary epithelial cells presenting bacterial ligands during liver inflammation
23. P1191 : Increased IgG4 responses to multiple environmental antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in autoimmune pancreatitis and IgG4 -related cholangitis
24. PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
25. P1191 HETEROGENEOUS EVOLUTIONARY DYNAMICS OF CHRONIC HEPATITIS-C INFECTION PREDICT LONG-TERM PERSISTENCE OF VIRUS THROUGH TREATMENT
26. P1241 A FULLY-AUTOMATED PIPELINE FOR SEQUENCING WHOLE VIRAL GENOMES WITHOUT VIRUS-SPECIFIC PCR AMPLIFICATION TO DETERMINE HCV RESISTANCE TO ANTIVIRAL THERAPY
27. P231 HEPATITIS C VIRUS POTENTLY ACTIVATES HUMAN CD161/MAIT (MUCOSAL ASSOCIATED INVARIANT T) CELLS
28. P355 GENE EXPRESSION ANALYSIS IDENTIFIES IMMUNE SIGNALING AND COMPLEMENT PATHWAYS IN IgG4-RELATED DISEASE
29. O161 CROSS-REACTIVITY OF HCV SPECIFIC, VACCINE INDUCED T CELLS, USING AN IN VITRO PRIMING MODEL
30. SAT-391 - IGG4-Related Disease is Associatied with CD4+ T Cell Activation and Regulation
31. SAT-376 - Helicobacter Pylori as a Microbial Antigen in IGG4-Related Disease
32. FRI-235 - Vaccine-Induced HCV-Specific CD8+ T Cell Response Restricted by the Protective HLA Allele B*27: Broad Cross-Recognition of Evolving Viral Variants
33. FRI-209 - The Generation of an Immunogenic Second-Generation Conserved Segment HCV T Cell Vaccine to Target Multiple HCV Genotypes
34. THU-262 - Genome-To-Genome Virus-Host Analysis Reveals HCV Genotype 3 Viral Polymorphisms Linked Viral Load and to Host HLA Class-I/II and IL28B Alleles
35. THU-253 - Comparison of next Generation Sequencing Technologies for the Comprehensive Assessment of Full-Length Hepatitis C Viral Genomes
36. THU-252 - Sequencing Methods Developed for Hepatitis C Identifies a New Virus, Human Hepegivirus 1, in Patients with Advanced Cirrhosis
37. PS031 - Characterisation of the Specificity, Functionality and Durability of Host T-Cell Responses against the Full HEV Genome
38. 974 SEROPREVALENCE OF HEPATITIS E IN THE SOUTH PACIFIC ISLANDS
39. 1183 IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION
40. 1383 IGG4-PLASMA CELL INFILTRATE IN THE LIVER AND COLON OF CHILDREN WITH PRIMARY SCLEROSING CHOLANGITIS
41. 45 RAPID AND EFFICIENT ANTIGEN PROCESSING AND PRESENTATION OF A PROTECTIVE AND IMMUNODOMINANT HLA-B*27-RESTRICTED HEPATITIS C VIRUS-SPECIFIC CD8+ T CELL EPITOPE
42. 65 A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
43. 1140 PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
44. 85 IL28B GENETIC STATUS IN ASSOCIATION WITH HCV SPECIFIC T-CELL IMMUNITY
45. 276 MULTIPLE NOVEL PEPTIDE EPITOPES IN HCV GENOTYPE-3A IDENTIFIED USING TWO PARALLEL APPROACHES
46. 707 CD8AA T CELLS: A NOVEL LINEAGE ENRICHED IN THE LIVER IN CHRONIC HCV
47. 1051 PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
48. [443] HIGH DOSE INTERFERON-ALPHA INDUCTION THERAPY IS ASSOCIATED WITH A PROFOUND LOSS OF IL-2 AND IFN-y SECRETING HCV SPECIFIC T-CELLS
49. [784] EXHAUSTION OF VIRUS SPECIFIC CD4+ T CELLS DURING ACUTE HEPATITIS C
50. Do mutations in CD 81 affect clinical outcome in patients with chronic hepatitis C infection?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.